We specialize in efficacy evaluation services optimized for specific disease models, offering differentiated data by focusing on particular therapeutic areas instead of adopting a “department store” approach like general CROs.

Our expertise is especially centered on Anticancer, Metabolic Diseases, and Liver Diseases.